These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2296879)

  • 1. Benefit and risks of long-term amiodarone therapy for sustained ventricular tachycardia/fibrillation: minimum of three-year follow-up in 145 patients.
    Myers M; Peter T; Weiss D; Nalos PC; Gang ES; Oseran DS; Mandel WJ
    Am Heart J; 1990 Jan; 119(1):8-14. PubMed ID: 2296879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation.
    Herre JM; Sauve MJ; Malone P; Griffin JC; Helmy I; Langberg JJ; Goldberg H; Scheinman MM
    J Am Coll Cardiol; 1989 Feb; 13(2):442-9. PubMed ID: 2913120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment of ventricular tachycardia with amiodarone in presence of severe left ventricular dysfunction.
    Burckhardt D; Robertson A; Hoffmann A; Pfisterer M
    J Clin Pharmacol; 1991 Nov; 31(11):1105-8. PubMed ID: 1753016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction.
    Piccini JP; Schulte PJ; Pieper KS; Mehta RH; White HD; Van de Werf F; Ardissino D; Califf RM; Granger CB; Ohman EM; Alexander JH
    Crit Care Med; 2011 Jan; 39(1):78-83. PubMed ID: 20959785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of malignant ventricular tachyarrhythmia with amiodarone: comparison of empirical administration and administration guided by Holter or ventricular stimulation. Results of the parallel test].
    Raviele A; Di Pede F; Gasparini G; Zanocco A; Delise P; Bonso A; D'Este D; Piccolo E
    G Ital Cardiol; 1991 Mar; 21(3):259-69. PubMed ID: 1894120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrhythmias.
    Anastasiou-Nana MI; Anderson JL; Nanas JN; Lutz JR; Smith RA; Anderson KP; Crapo RO; Call NB
    Can J Cardiol; 1986; 2(3):138-45. PubMed ID: 2941121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous amiodarone for short-term treatment of refractory ventricular tachycardia or fibrillation.
    Nalos PC; Ismail Y; Pappas JM; Nyitray W; DonMichael TA
    Am Heart J; 1991 Dec; 122(6):1629-32. PubMed ID: 1957758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.
    Cairns JA; Connolly SJ; Roberts R; Gent M
    Lancet; 1997 Mar; 349(9053):675-82. PubMed ID: 9078198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.
    McGovern B; Garan H; Malacoff RF; DiMarco JP; Grant G; Sellers TD; Ruskin JN
    Am J Cardiol; 1984 Jun; 53(11):1558-63. PubMed ID: 6731300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiodarone in patients with recurrent sustained ventricular tachyarrhythmias: results of programmed electrical stimulation and long-term clinical outcome in chronic treatment.
    Schmitt C; Brachmann J; Waldecker B; Rizos I; Senges J; Kübler W
    Am Heart J; 1987 Aug; 114(2):279-83. PubMed ID: 3604883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amiodarone and sustained ventricular arrhythmias: statistical evidence of drug effectiveness.
    Flaker GC; Alpert MA; Webel RR; Ruder MA; Sanfelippo JF; Tsutakawa RK
    Am Heart J; 1985 Aug; 110(2):371-6. PubMed ID: 4025112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk stratification and prognosis of patients treated with amiodarone for malignant ventricular tachyarrhythmias after myocardial infarction.
    Proclemer A; Facchin D; Vanuzzo D; Feruglio GA
    Cardiovasc Drugs Ther; 1993 Aug; 7(4):683-9. PubMed ID: 8241012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of intravenous amiodarone in the short term treatment of recurrent sustained ventricular tachycardia and ventricular fibrillation.
    Schützenberger W; Leisch F; Kerschner K; Harringer W; Herbinger W
    Br Heart J; 1989 Nov; 62(5):367-71. PubMed ID: 2590589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of postmyocardial infarction patients with ventricular tachycardia or ventricular fibrillation treated with amiodarone.
    Strasberg B; Kusniec J; Zlotikamien B; Mager A; Sclarovsky S
    Am J Cardiol; 1990 Sep; 66(7):673-8. PubMed ID: 2399883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Empiric treatment with amiodarone in patients with sustained ventricular tachyarrhythmia. Results of a long-term follow-up].
    Di Pede F; Raviele A; Gasparini G; Caprioglio F; Zanocco A; Delise P; Bonso A; D'Este D; Piccolo E
    G Ital Cardiol; 1990 Sep; 20(9):819-27. PubMed ID: 2079183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stratification of sudden death risk in patients receiving long-term amiodarone treatment for sustained ventricular tachycardia or ventricular fibrillation.
    Olson PJ; Woelfel A; Simpson RJ; Foster JR
    Am J Cardiol; 1993 Apr; 71(10):823-6. PubMed ID: 8456761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation.
    Heger JJ; Prystowsky EN; Zipes DP
    Am Heart J; 1983 Oct; 106(4 Pt 2):887-94. PubMed ID: 6613835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of the changes in the mode of ventricular tachycardia induction during therapy with amiodarone or amiodarone and a class 1A antiarrhythmic agent.
    Kim SG; Felder SD; Figura I; Johnston DR; Mercando AD; Fisher JD
    Am J Cardiol; 1987 Jun; 59(15):1314-8. PubMed ID: 3591686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of ventricular fibrillation predicts sudden death in patients treated with amiodarone because of ventricular tachyarrhythmias after a myocardial infarction.
    Rodríguez LM; Sternick EB; Smeets JL; Timmermans C; den Dulk K; Oreto G; Wellens HJ
    Heart; 1996 Jan; 75(1):23-8. PubMed ID: 8624866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
    Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
    N Engl J Med; 1997 Nov; 337(22):1576-83. PubMed ID: 9411221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.